Jump to content

Search the Community

Showing results for tags 'survival'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • COMMUNITY
    • Announcements, meetings and other resources
  • ADVANCED PROSTATE CANCER FORUMS
    • Primary hormone therapy
    • Secondary hormone therapy
    • Castrate Resistant Prostate Cancer
    • Metastatic
    • Very high risk
    • New agents
    • Every little bit helps
    • Radiation, diagnostic imaging, bones and other prostate cancer topics
    • Articles on other sites
  • MEMBER'S STORIES AND NEEDS
    • My story
    • Any suggestions?
    • The lounge

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Found 4 results

  1. During the phone-in meeting we held this morning (23 March 2018), there was discussion about Xofigo (Radium-223). The question arose of whether Xofigo gave both pain relief and longer survival. During that discussion, I mentioned that I had discussed Xofigo with American Medical Oncologist Alicia Morgans, and that this was on video. This is the video: A report on the ALSYMPCA trial of Xofigo (Radium-223) (previously called Alpharadin) can be found here. http://www.nejm.org/doi/full/10.1056/NEJMoa1213755 You can find all our videos on our YouTube
  2. I noticed a few minutes ago that the JimJimJimJim YouTube Channel has clicked up 50,000 views. That's a lot of help and comfort that men and their partners have found in understanding advanced prostate cancer - their disease, their treatments, and the journey of others. The top topic - Gleason score in advanced prostate cancer Click the picture to view the video. Closed captions Cc for the hard of hearing. The top story - David's story - 7 years with metastatic prostate cancer Click the picture to view the video. Closed captions Cc for the
  3. Jim Marshall (not a doctor) said ... How many doses of the chemotherapy drug Taxotere (Docetaxel) will give longest survival? The number of doses you get depends on how your cancer is responding, and how your body is dealing with it. Six doses of Docetaxel seems to be a common aim (as in the CHARTED trial): But doctors give as many as 10 or more Docetaxel doses in a row (and may repeat that in the future if the first sessions gave a good result). No one has done a study to see if giving more than six doses in a row gives longer survival. But as part of ano
  4. A recent study has found that higher vitamin D Levels were associated with longer prostate cancer survival. Reference: Mondul, A. et al. Circulating 25-hydroxyvitamin D and prostate cancer survival. Cancer Epidemiology, Biomarkers & Prevention, 2016. The research has also been reported in an article by the US Vitamin D Council This article is probably easier to read than the scientific reference mentioned above.
×
×
  • Create New...